Cargando…

Factor Structure of the Targeted Inventory on Problems in Schizophrenia

OBJECTIVE: The aim of this study was to explore the factor structure of a novel, 10-item rating scale, the Targeted Inventory on Problems in Schizophrenia (TIP-Sz). Determining the factor structure will be useful in the brief evaluation of medication and non-medication treatment of the disease. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Shoji, Nagase, Takanori, Suzuki, Takefumi, Nomura, Kensuke, Takeuchi, Hiroyoshi, Nakajima, Shinichiro, Uchida, Hiroyuki, Yagi, Gohei, Watanabe, Koichiro, Mimura, Masaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650293/ https://www.ncbi.nlm.nih.gov/pubmed/23678350 http://dx.doi.org/10.9758/cpn.2013.11.1.18

Ejemplares similares

Dental conditions in inpatients with schizophrenia: A large-scale multi-site survey
por: Tani, Hideaki, et al.
Publicado: (2012)

Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data
por: Tsujii, Takashi, et al.
Publicado: (2022)

Effectiveness of Saikokaryukotsuboreito (Herbal Medicine) for Antipsychotic-Induced Sexual Dysfunction in Male Patients with Schizophrenia: A Description of Two Cases
por: Takashi, Tsuboi, et al.
Publicado: (2014)

Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross‐sectional study
por: Takahashi, Kie, et al.
Publicado: (2020)

Asymptomatic Deep Vein Thrombosis in a Patient with Major Depressive Disorder
por: Ishida, Takuto, et al.
Publicado: (2012)

Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder
por: Nomura, Kensuke, et al.
Publicado: (2021)

Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series
por: Tani, Hideaki, et al.
Publicado: (2021)

Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies
por: Ueno, Fumihiko, et al.
Publicado: (2019)

T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
por: Uchida, Hiroyuki, et al.
Publicado: (2020)

Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study
por: Nomura, Nobuyuki, et al.
Publicado: (2021)

Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)
por: Kitagawa, Kohei, et al.
Publicado: (2020)

Drug Attitude, Insight, and Patient’s Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey
por: Nagai, Nobuhiro, et al.
Publicado: (2020)

PM398. Fluctuations in hallucinatory experiences within a day in relation to dopamine D2 receptor blockade with antipsychotics in patients with schizophrenia
por: Koizumi, Teruki, et al.
Publicado: (2016)

Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia
por: Ogyu, Kamiyu, et al.
Publicado: (2020)

Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study
por: Kitahata, Ryosuke, et al.
Publicado: (2017)

PS164. Concomitant Use of Benzodiazepine Hypnotics and Alcohol in Patients with Schizophrenia, Depression and Insomnia: A Preliminary Finding
por: Uchida, Takahito, et al.
Publicado: (2016)

TMS-EEG Research to Elucidate the Pathophysiological Neural Bases in Patients with Schizophrenia: A Systematic Review
por: Li, Xuemei, et al.
Publicado: (2021)

Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus
por: Sakurai, Hitoshi, et al.
Publicado: (2021)

Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levels
por: Ochi, Ryo, et al.
Publicado: (2022)

Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia
por: Itahashi, Takashi, et al.
Publicado: (2021)

M23. ALTERATION OF REGIONAL CEREBRAL BLOOD FLOW MEASURED BY ARTERIAL SPIN LABELING IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Ogyu, Kamiyu, et al.
Publicado: (2020)

Fear Conditioning Induced by Interpersonal Conflicts in Healthy Individuals
por: Tada, Mitsuhiro, et al.
Publicado: (2015)

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia
por: Hirano, Jinichi, et al.
Publicado: (2013)

T212. LEVELS OF GLUTAMATERGIC NEUROMETABOLITES IN PATIENTS WITH SEVERE TREATMENT-RESISTANT SCHIZOPHRENIA: A PROTON MAGNETIC RESONANCE SPECTROSCOPY STUDY
por: Tarumi, Ryosuke, et al.
Publicado: (2020)

PT594. Placebo effects in Alzheimer Disease: analysis of the CATIE-AD data
por: Ozawa, Chisa, et al.
Publicado: (2016)

Patterns of functional connectivity alterations induced by alcohol reflect somatostatin interneuron expression in the human cerebral cortex
por: Ochi, Ryo, et al.
Publicado: (2022)

Persistence and compliance to antidepressant treatment in patients with depression: A chart review
por: Sawada, Norifusa, et al.
Publicado: (2009)

PT567. Improvement to antipsychotic treatment at week 2 predicts subsequent treatment response in behavioral and psychological symptoms with dementia: Analysis of the CATIE-AD data
por: Yoshida, Kazunari, et al.
Publicado: (2016)

Development of an Advanced Sham Coil for Transcranial Magnetic Stimulation and Examination of Its Specifications
por: Takano, Mayuko, et al.
Publicado: (2021)

The cost of schizophrenia in Japan
por: Sado, Mitsuhiro, et al.
Publicado: (2013)

Psychometric properties of Drug Attitude Inventory among patients with schizophrenia
por: Sowunmi, Oladipo A.
Publicado: (2022)

Metabolites for monitoring symptoms and predicting remission in patients with depression who received electroconvulsive therapy: a pilot study
por: Uchida, Takahito, et al.
Publicado: (2023)

S16. GLUTAMATERGIC NEUROMETABOLITE LEVELS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA: A CROSS-SECTIONAL 3T PROTON MRS STUDY
por: Iwata, Yusuke, et al.
Publicado: (2018)

Melancholic and reactive depression: a reappraisal of old categories
por: Mizushima, Jin, et al.
Publicado: (2013)

Combined Clozapine and Electroconvulsive Therapy in a Japanese Schizophrenia Patient: A Case Report
por: Yoshino, Yuta, et al.
Publicado: (2014)

Photobiological Neuromodulation of Resting-State EEG and Steady-State Visual-Evoked Potentials by 40 Hz Violet Light Optical Stimulation in Healthy Individuals
por: Noda, Yoshihiro, et al.
Publicado: (2021)

Resting-State Isolated Effective Connectivity of the Cingulate Cortex as a Neurophysiological Biomarker in Patients with Severe Treatment-Resistant Schizophrenia
por: Wada, Masataka, et al.
Publicado: (2020)

M58. EVALUATING WEIGHTINGS OF PREDICTIVE AND POSTDICTIVE PROCESSES IN ABERRANT SENSE OF AGENCY IN SCHIZOPHRENIA
por: Oi, Hiroki, et al.
Publicado: (2020)

Minnesota Multiphasic Personality Inventory Characteristics of Parricide Offenders with Schizophrenia in Korea
por: Lee, Sang Yeop, et al.
Publicado: (2017)

Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
por: Harada, Eiji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_unco4vhf61e855k0307mcp7fen